Global Antacids Market Poised to Gain Significant Growth in Coming Years: Proton Pump Inhibitor Drug Holds Dominant Position till 2025

Market Research HUB Market Research HUB

Albany, US, 2017-Nov-14 — /EPR Network/ —Recently, a new study on the global antacids market has been added to the broad portfolio of Market Research Hub (MRH), which reveals that the market has been displaying steady growth, and going forward it is likely to remain this way. Antacids are widely used to treat acid reflux that causes heartburn, indigestion, and stomach upset. They provide quick relief from heartburn that is why considered as a preferable option for medication. Due to the growing trend of self-medication for occasional heartburn and acidity and the easy availability of antacids over the counter is driving the sales of antacids worldwide and thus propelling its market growth. The study is titled as “Antacids Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025” and analyzes the current and future prospects of the market. In order to explain the intensity of competition in the market, the report has been segmented geographically into major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Request For Free Sample Report:

According to the research, the changing dietary habits and growing geriatric population worldwide are two important drivers in the global antacids market. The elderly population that is more susceptible to gastroesophageal reflux diseases (GERD) and peptic ulcers is anticipated to account for significant demand for antacids. As per estimates of the report, the global antacids market will clock a 3.7% CAGR between 2017 and 2025 to reach a valuation of US$18.7 bn by 2025 end. Geography-wise, Europe emerged as the most lucrative market for antacids in 2016 because of the rising number of elderly population.

In the initial section, the report begins with an executive summary which offers highlights and gist of the report. The succeeding sections involve information on the leading drivers, trends, opportunities, and restraints that the global antacids industry players are facing currently. It has been stated in the report that development of novel therapies and new formulations of existing drugs is what leading players in this market are concentrating on to gain competitive advantage. In this subsequent section, Porter’s five force analysis and market attractiveness analysis has also included.

Further, the report segments global antacids market on the basis of drug class, formulation type, distribution channel, and geography. Based on drug class, global antacids market is segmented into proton pump inhibitor (PPI), H2 antagonists and acid neutralizers. Of them, proton pump inhibitors led the market in 2016 and the trend is anticipated to continue over the forecast period. They are mainly used to treat gastroesophageal reflux diseases (GERD), peptic ulcers, etc. Also, because of their effectiveness, easy availability as prescription and over the counter drugs as an affordable price. On the basis of formulation type, it includes tablet, liquid, powder and others. Besides, Retail pharmacies segment in distribution channel is anticipated to hold significant share and have steady growth during the forecast period.

Browse Full Report with TOC:-

The report concludes with the profiles of major players in the global gastrointestinal drugs market such as AstraZeneca, Sun Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Pfizer Inc., Bayer AG, Procter & Gamble, Boehringer Ingelheim GmbH, Johnson & Johnson, Sanofi, Takeda Pharmaceutical, Reckitt Benckiser Group plc, Valeant Pharmaceuticals International, Inc., among others. This competitive analysis positions all major players depending on their presence in different regions of the world, coupled with recent key developments introduced by them in the market.

Enquire About This Report:

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of pharmaceutical market reports and analysis. MRH’s expansive collection of reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,
Albany, NY 12207,
United States

Toll Free: 800-998-4852 (US-Canada)
Read Industry News at –


Matched content

Editor’s pick